Search

Search Results

• PO:30:153 | Long-term outcomes of JIA-associated uveitis: a systematic review and meta-analysis Laura Scagnellato¹, Giacomo Cozzi¹, Matteo Molfese¹, Mariagrazia Lorenzin¹, Jamie Alexander King¹, Gianluca Poncina¹, Stefano Rizzetto¹, Roberta Ramonda¹ | ¹UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2363

  43
• 

  Jaccoud’s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment

  M. Benucci, A. Damiani, F. Li Gobbi, V. Grossi, M. Infantino, A. Arena, M. Manfredi

  88-91

  03-08-2017

  https://doi.org/10.4081/reumatismo.2017.968

  2392

  PDF: 1119

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  https://doi.org/10.4081/reumatismo.2008.61

  1310

  PDF: 948

• Temporomandibular joint involvement in juvenile idiopathic arthritis: treatment with an orthodontic appliance

  C. Bellintani, P. Ghiringhelli, V. Gerloni, M. Gattinara, G. Farronato, F. Fantini

  201-207

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.201

  1637

  PDF: 1910

• Anti-chromatin antibodies in juvenile rheumatoid arthritis

  F. Ingegnoli, N. Del Papa, E. Lupi, D.P. Comina, W. Maglione, V. Gerloni, F. Fantini

  240-244

  https://doi.org/10.4081/reumatismo.2003.240

  1357

  PDF: 1043

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1525

  PDF: 954

• PO:10:150 | A case of pulmonary hypertension in Whipple's disease Alba Chiara Pozzi^1|2, Giulia Fontana^1|2, Francesca Crisafulli^1|2, Guarino Daniele³, Monica Salvi³, Massimiliano Palazzini³, Francesco Biagi^4|5, Ilaria Cavazzana^1|2, Franco Franceschini^1|2, Micol Frassi¹. | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, Brescia, Italy; ²Department of Clinical Experimental Sciences, University of Brescia, Brescia; ³IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Cardiology Unit, DIMEC, Bologna; ⁴University of Pavia, Department of Internal Medicine and Therapeutics, Pavia; ⁵Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2026

  133

• PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs? Laura Scagnellato¹, Giacomo Cozzi¹, Mariagrazia Lorenzin¹, Mariangela Salvato¹, Alessandro Giollo¹, Bernd Raffeiner¹, Antonia Calligaro¹, Teresa Del Ross¹, Sara Bindoli¹, Margherita Zen¹, Paolo Sfriso¹, Andrea Doria¹, Roberta Ramonda¹. | ¹UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2003

  162

• PO:15:212 | Anifrolumab induces a rapid improvement in joint inflammation in Systemic Lupus Erythematosus patients: an ultrasonographic study Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Valerio Fiorilli, Francesca Romana Spinelli, Fabrizio Conti | Sapienza Università di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2326

  13

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1561

  PDF: 1151

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  840

  PDF: 773

• Anti-tissue transglutaminase antibodies in inflammatory and degenerative arthropathies

  A. Spadaro, M.L. Sorgi, R. Scrivo, A. Picarelli, M. Di Tola, L. Sabbatella, E. Taccari

  344-350

  https://doi.org/10.4081/reumatismo.2002.344

  1223

  PDF: 1729
• 

  Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

  G. El Hasbani, A. Jawad, I. Uthman

  59-63

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1374

  5776

  PDF: 1594

• Knee radiosynovectomy with Y90 in patients with rheumatoid arthritis: our experiences

  W. Troise Rioda, A. Nervetti, G. Ugolotti, G. Adorni

  206-211

  https://doi.org/10.4081/reumatismo.2008.206

  1184

  PDF: 1902

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  https://doi.org/10.4081/reumatismo.2007.66

  1878

  PDF: 1150

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1227

  PDF: 1845
• 

  The diagnostic utility of miRNA21 in systemic sclerosis

  Gehad Gamal Maghraby, May Mohsen Tolba Fawzi, Laila Ahmed Rashed, Mohamed Tharwat Hegazy

  25-09-2025

  https://doi.org/10.4081/reumatismo.2025.1773

  981

  PDF: 123

  SUPPLEMENTARY MATERIAL: 33

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  https://doi.org/10.4081/reumatismo.2009.182

  1112

  PDF: 788

• CO:10:4 | Lung vasculature quantification on computed tomography predicts new onset of interstitial lung disease in systemic sclerosis Maria Iacovantuono^1|2, Nicholas Landini^2|3, Lisa Jungblut⁴, Gesa Sauer², Rucsandra Dobrota², Maria Sinziana Muraru-Carbune², Muriel Elhai², Carmen-Marina Mihai², Mike Oliver Becker², Maria Sole Chimenti¹, Thomas Frauenfelder⁴, Anna-Maria Hoffmann-Vold⁵, Oliver Distler², Cosimo Bruni². | ¹Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy; ²Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland; ³Department of Radiological Sciences, Oncology and Pathology, Sapienza University, Policlinico Umberto I, Rome, Italy; ⁴Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Switzerland; ⁵Department of Rheumatology, Oslo University Hospital, Norway

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1993

  138

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  2082

  PDF: 2203

• Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disabilty

  G. Cuomo, P. Di Micco, A. Niglio, G. La Montagna, G. Valentini

  242-246

  https://doi.org/10.4081/reumatismo.2004.242

  1655

  PDF: 1354

• PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2043

  134
• 

  Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study

  A.M. Elsaman, A. Sayed, A.R. Radwan

  131-144

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1273

  1722

  PDF: 943

• Cardiac involvement in rheumatoid arthritis

  M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini

  244-253

  https://doi.org/10.4081/reumatismo.2009.244

  2147

  PDF: 1422

• Tenosynovitis of the ankles as onset of sarcoidosis in a patient with ulcerative colitis

  A. Furlan, M. Podswiadek, F. Cozzi, S. Todesco

  197-200

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.197

  1585

  PDF: 1496

• PO:04:056 | Willingness of patients with psoriatic arthritis to participate in pharmacological and nutritional clinical trials: a cross-sectional study Miriam Perino^1|2, Francesca Ingegnoli^1|2, Luca Ingrao^1|2, Debora Piredu^1|2, Antonio Varvaro^1|2, Camilla Riboldi^1|2, Gilberto Cincinelli², Francesca Desiati², Martina Biggioggero², Orazio De Lucia², Silvia Casari², Maria Manara², Ennio Giulio Favalli^1|2, Roberto Caporali^1|2 | ¹Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Milano; ²ASST G. Pini-CTO, UOC di Clinica Reumatologica, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2131

  135

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1593

  PDF: 1108

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  799

  PDF: 756

• PO:01:014 | Differential inflammatory responses of CD14+ and CD14– synoviocytes in psoriatic arthritis: implications for pathogenesis and targeted therapies Monia Maccaferri¹, Monica Montanari², Francesco Zambianchi^3|4, Carlo Salvarani^1|5, Elisa Pignatti^1|4 | ¹Dipartimento CHIMOMO; ²Dipartimento di Scienze e Vita; ³Dipartimento SMECHIMAI Università di Modena e Reggio Emilia; ⁴Azienda Ospedaliero Universitaria di Modena; ⁵Struttura Complessa di Reumatologia, Azienda Unità Sanitaria Locale di Reggio Emilia-IRCCS, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2123

  141
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  4170

  PDF: 691

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1278

  PDF: 878

• Diff-Quik® staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids

  S. Manganelli, E. Selvi, M. Catenaccio, S. Cucini, R. De Stefano, E. Frati, M. Hammoud, R. Marcolongo

  305-308

  https://doi.org/10.4081/reumatismo.2001.305

  1532

  PDF: 951

• CO:04:1 | Bone properties and biomechanics in patients with psoriatic disease: a cross-sectional study with high-resolution peripheral quantitative computed tomography Anna Piccinelli¹, Francesco Bellinato², Francesco Pollastri¹, Francesco Giorgio¹, Martina Teoni¹, Angelo Fassio¹, Camilla Benini¹, Carmela Dartizio¹, Mattia Tugnolli¹, Davide Gatti¹, Maurizio Rossini¹, Ombretta Viapiana¹, Paolo Gisondi², Giovanni Adami¹. | ¹Rheumatology Unit, University of Verona; ²Dermatology Unit, University of Verona, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1969

  178
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  2150

  PDF: 538
• 

  Treatment of hyperuricemia, gout and other crystalline arthritidies

  F. Lioté

  276-283

  https://doi.org/10.4081/reumatismo.2011.276

  1393

  PDF: 1332

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  1097

  PDF: 1012

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  https://doi.org/10.4081/reumatismo.2003.52

  1212

  PDF: 4893

• PO:04:061 | Higher prevalence of baseline comorbidities in patients developing difficult to treat psoriatic arthritis Mario Ferraioli¹, Michelina Turri¹, Eneida Çela¹, Mauro Fatica¹, Paola Conigliaro¹, Elisabetta Greco¹, Alberto Bergamini¹, Maria Sole Chimenti¹. | ¹Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome, Tor Vergata, Rome, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2011

  133

• PO:20:005 | Sarcopenia and fracture risk in rheumatoid arthritis: correlation between SACR-F and fragility score measured by radiofrequency echographic multi-spectrometry Sara Torracchi¹, Pamela Bernardini¹, Daniela Melchiorre¹, Bianca Bossi¹, Dorilda Zeka¹, Francesca Nacci¹, Lorenzo Tofani¹, Serena Guiducci¹ | ¹SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2174

  155

• PO:08:114 | The adjuvanted recombinant zoster vaccine is effective in preventing herpes zoster among patients ≥50 years of age with selected autoimmune diseases in the united states: a real-world database analysis (2018–2021) Rosaria Silvestri¹, Dagna Constenla², Germain Lonnet³, Emmanuel Aris³, Nathalie Servotte³, Ramsanjay Rk⁴, Agnes Mwakingwe-Omari², Huifeng Yun² | ¹GSK Verona, Italy; ²GSK Rockville, USA; ³GSK Wavre, Belgium; ⁴GSK Bengaluru, India

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2140

  158
• 

  Extra-articular rheumatoid arthritis

  E. Marcucci, E. Bartoloni, A. Alunno, M.C. Leone, G. Cafaro, F. Luccioli, V. Valentini, E. Valentini, G.M.C. La Paglia, A.F. Bonifacio, R. Gerli

  212-224

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1106

  10088

  PDF: 4902

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1685

  PDF: 1073

• CO:07:3 | Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in difficult-to-treat psoriatic arthrtis patients? Results from a cross-sectional study Fabio Massimo Perrotta¹, Alen Zabotti², Mauro Fatica¹, Nicola Cabas², Andrea Guiotto², Nicoletta Franzolini³, Giovanni Striani², Maria De Martino⁴, Cristina De Nicola⁵, Miriam Isola⁴, Andrea Di Matteo⁶, Gabriele De Marco⁶, Denis McGonagle⁶, Ennio Lubrano¹, Luca Quartuccio⁴. | ¹Università degli studi del Molise, Campobasso; ²University Hospital Santa Maria della Misericordia, Udine; ³Presidio Ospedaliero S. Antonio, San Daniele del Friuli (UD); ⁴University of Udine; ⁵Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy; ⁶University of Leeds, Leeds, UK

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1978

  137

• PO:06:081 | Safety of JAK inhibitors compared to non-TNF-targeted biologic therapies in rheumatoid arthritis patients who are inadequate responders to TNF inhibitors Lorenzo Di Luozzo¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Kiren Khalid¹, Margherita Zen¹, Andrea Doria¹ | ¹Azienda ospedaliera universitaria di Padova, unità di Reumatologia, Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2298

  37
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  5062

  PDF: 3276

• Study of vitamin D status of rheumatoid arthritis patients Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)

  B. Frediani, M. Rossini, S. Adami, G. Bianchi, O. Di Munno, L. Sinigaglia, M. Antonelli, G. Minisola

  314-318

  https://doi.org/10.4081/reumatismo.2006.314

  1649

  PDF: 2212

• PO:01:008 | Active sacroiliitis at magnetic resonance enterography increases the risk of axial spondyloarthritis in Crohn’s disease patients, while greater age and disease duration are protective factors: a monocentric retrospective cohort study Gabriele Amati¹, Gilda Sandri^1|2, Giovanni Ciancio², Benedetta Bongiovanni^1|2, Martina Orlandi^1|2, Ottavio Secchi^1|2, Davide Vaccari³, Annarita Pecchi⁴, Angela Bertani⁵, Maddalena Pecchini⁵, Pietro Torricelli⁴, Antonio Colecchia⁵, Dilia Giuggioli^1|2. | ¹Struttura Complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; ²Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia, Modena, Italy; ³Unità Operativa di Radiologia, Ospedale di Pavullo, AUSL di Modena, Modena, Italy; ⁴Struttura Complessa di Radiologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; ⁵Struttura Complessa di Gastroenterologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2005

  176
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1856

  PDF: 1262

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1564

  PDF: 1204

• PO:01:010 | Survival of second-line treatment with TNF inhibitors vs. IL-23 inhibitors after failure of a first TNF inhibitor: a real-life observational study from the Italian multicenter BIRRA cohort in patients with psoriatic arthritis Francesca Ometto¹, Olga Addimanda², Bernd Raffeiner³, Alberto Lo Gullo⁴, Elisa Visalli⁵, Eleonora Celletti⁶, Antonella Farina⁷, Maddalena Larosa⁸, Romina Andracco⁹, Marino Paroli¹⁰, Patrizia Del Medico¹¹, Aldo Biagio Molica Collella¹², Federica Lumetti¹³, Gilda Sandri¹⁴, Marta Priora¹⁵, Aurora Ianiello¹⁶, Elena Bravi¹⁷, Alessandra Bezzi¹⁸, Palma Scolieri¹⁹, Simone Parisi²⁰, Viviana Ravagnani²⁰, Rosetta Vitetta²⁰, Luca Idolazzi²⁰, Riccardo Bixio²⁰, Gianluca Santoboni²⁰, Francesco Girelli²⁰, Alarico Ariani²⁰ | ¹Azienda ULSS 6 Euganea, Padova; ²UOC Interaziendale di Medicina Interna ad Indirizzo Reumatologico, AUSL BO - IRCCS AOU Bologna; ³Unità di Reumatologia, Teaching Hospital of the Paracelsius Medical University, Central Hospital of Bolzano (ASAA-SABES) Bolzano; ⁴UOD Reumatologia, ARNAS Garibaldi Catania; ⁵UO Reumatologia, Policlinico San Marco Hospital Catania; ⁶UOS Reumatologia, Ospedale SS. Annunziata, Università G. d'Annunzio, Chieti; ⁷UOC Medicina Interna- Ambulatorio Reumatologico, Ospedale A. Murri, Fermo; ⁸S.C. Reumatologia, Dipartimento Specialità Mediche, Ospedale La Colletta-Azienda Sanitaria Locale 3 Genova; ⁹Ambulatorio Reumatologia, Ospedale di Imperia; ¹⁰Sapienza Università Polo Pontino, Latina; ¹¹Ambulatorio di Reumatologia, UO Medicina Interna, Civitanova Marche Hospital, Civitanova (MC); ¹²UOSD di Reumatologia, Azienda Ospedaliera Papardo Messina; ¹³Unità di Reumatologia, Azienda USL di Modena e Ospedale Universitario Policlinico di Modena; ¹⁴Unità di Reumatologia, Università di Modena e Reggio Emilia Modena; ¹⁵Ambulatorio e Day Hospital di Reumatologia, ASL CN1, Mondovì (CN); ¹⁶Poliambulatorio specialistico di reumatologia e Day Hospital multidisciplinare di area Medica, ASL Novara; ¹⁷UOSD Reumatologia, Ospedale G. Da Saliceto, Piacenza; ¹⁸UO Medicina Interna e Reumatologia, SS Reumatologia, ASL Romagna, Rimini; ¹⁹UOC Medicina Interna e Reumatologia, Ospedale Nuovo Regina Margherita, Roma; ²⁰Gruppo BIRRA Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2122

  175